1. Home
  2. AEE vs DXCM Comparison

AEE vs DXCM Comparison

Compare AEE & DXCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AEE
  • DXCM
  • Stock Information
  • Founded
  • AEE 1901
  • DXCM 1999
  • Country
  • AEE United States
  • DXCM United States
  • Employees
  • AEE N/A
  • DXCM N/A
  • Industry
  • AEE Power Generation
  • DXCM Medical/Dental Instruments
  • Sector
  • AEE Utilities
  • DXCM Health Care
  • Exchange
  • AEE Nasdaq
  • DXCM Nasdaq
  • Market Cap
  • AEE 25.3B
  • DXCM 28.0B
  • IPO Year
  • AEE N/A
  • DXCM 2005
  • Fundamental
  • Price
  • AEE $89.77
  • DXCM $78.93
  • Analyst Decision
  • AEE Buy
  • DXCM Buy
  • Analyst Count
  • AEE 13
  • DXCM 17
  • Target Price
  • AEE $86.45
  • DXCM $98.00
  • AVG Volume (30 Days)
  • AEE 1.1M
  • DXCM 3.5M
  • Earning Date
  • AEE 11-06-2024
  • DXCM 02-06-2025
  • Dividend Yield
  • AEE 2.98%
  • DXCM N/A
  • EPS Growth
  • AEE N/A
  • DXCM 83.21
  • EPS
  • AEE 4.26
  • DXCM 1.67
  • Revenue
  • AEE $7,058,000,000.00
  • DXCM $3,954,000,000.00
  • Revenue This Year
  • AEE $5.37
  • DXCM $13.10
  • Revenue Next Year
  • AEE $5.63
  • DXCM $14.79
  • P/E Ratio
  • AEE $21.16
  • DXCM $47.32
  • Revenue Growth
  • AEE N/A
  • DXCM 16.19
  • 52 Week Low
  • AEE $67.03
  • DXCM $62.34
  • 52 Week High
  • AEE $95.69
  • DXCM $142.00
  • Technical
  • Relative Strength Index (RSI)
  • AEE 42.89
  • DXCM 57.86
  • Support Level
  • AEE $89.50
  • DXCM $77.33
  • Resistance Level
  • AEE $93.04
  • DXCM $81.12
  • Average True Range (ATR)
  • AEE 1.29
  • DXCM 2.49
  • MACD
  • AEE -0.60
  • DXCM -0.04
  • Stochastic Oscillator
  • AEE 4.36
  • DXCM 65.85

About AEE Ameren Corporation

Ameren owns rate-regulated generation, transmission, and distribution networks that deliver electricity and natural gas in Missouri and Illinois. It serves more than 2.4 million electricity customers and more than 900,000 natural gas customers.

About DXCM DexCom Inc.

Dexcom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery.

Share on Social Networks: